阿尔茨海默病中的表观遗传调节和营养相互作用:揭示潜在的治疗途径
Muhammad-Safuan Zainuddin1, Karshini Ghanesh1, Navishaa Ganesan1
1Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
Nutritional neuroscience
|July 17, 2025
概括
营养素可以影响阿尔茨海默氏症 (AD) 的表观遗传变化,可能带来治疗效益. 需要进一步的研究来澄清这些基于营养素的干预措施的确切作用机制.
科学领域:
- 神经科学是一个神经科学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 营养科学 营养科学
背景情况:
- 阿尔茨海默病 (AD) 是一种主要的神经退行性疾病,具有复杂的病理.
- 目前的AD治疗提供症状缓解,但不能阻止疾病的进展.
- 营养素在AD表观遗传学中的作用在很大程度上仍未被探索.
研究的目的:
- 审查阿尔茨海默氏病中的表观遗传变化.
- 探索营养暴露和AD中的表观遗传效应之间的关系.
- 确定潜在的基于营养的AD治疗策略.
主要方法:
- 对AD的体外,体内和临床研究的系统审查.
- 综合关于表观遗传机制 (DNA甲基化,基因质修饰,非编码RNAs) 的当前知识.
- 在AD的背景下探索营养素-表观遗传相互作用.
主要成果:
- 表观遗传机制在衰老和AD发展中起着重要作用.
- 营养素显示出调节AD表观遗传过程的潜力,影响粉样β和病理,氧化应激和认知功能.
- 在AD中营养素-表观遗传相互作用的确切作用机制尚未完全理解,因为发现不一致.
结论:
- 营养素会影响阿尔茨海默病中的表观遗传调节.
- 需要进行更全面的机制分析.
- 未来需要进行大规模研究,以建立明确的营养素-表观遗传关系,以便开发新的治疗干预措施.
关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.通过DNA甲基化.表观遗传学是指表观遗传学.微RNAs 是一个微型RNA.神经退行性疾病是一种神经退行性疾病.没有编码的RNAs.营养素 营养素 营养素维生素 维生素 维生素 是一种更多相关视频
相关概念视频
Alzheimer's Disease: Overview
673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673
Alzheimer's Disease: Treatment
263
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
263
Neural Regulation
40.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.2K
Human Genetics
732
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
732
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
212
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
212


